Your web browser is out of date. Update your browser for more security, speed and the best experience on this site.

Update your browser

Press & News

We love what we do. A lot of other important folks love it too. See what they have to say about us.

Public Relations: Andrew Noble

Press Releases

August 02, 2022

DNAnexus Named One of the 100 Best Workplaces for Innovators by Fast Company

MOUNTAIN VIEW, Calif. — Aug. 2, 2022 — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced that it was included in Fast Company’s fourth annual Best Workplaces for Innovators list, honoring organizations and businesses that demonstrate a steadfast commitment to encouraging innovation at all levels.

Read More
July 13, 2022

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems

Read More
March 18, 2022

DNAnexus Secures $200 Million Funding Led by Blackstone Growth

Bioinformatics company DNAnexus Inc. has raised $200 million in a financing round led by Blackstone Inc. funds. The series I round values the Mountain View, California-based company at about $600 million, said people familiar with the matter who asked not to be identified discussing it.

Read More

News Highlights

Media Coverage

March 18, 2022

Blackstone Growth Leads $200 Million Investment in DNAnexus

One or two lines of text from article goes here mollis, mauris orci dignissim nisl, id gravida nunc enim quis nibh. Maecenas convallis eros a ante dignissim, vitae elementum metus facilisis. Cras in maximus sem. Praesent libero augue, ornare eget quam sed, volutpat suscipit arcu.

Read More
  • DNAnexus Solutions are used by......

  • 7 of the world’s top 10 pharmaceutical companies

  • 8 of the 10 biggest diagnostics developers

Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases.

James R. Downing, President & CEO
St. Judes Children’s Research Hospital

I consent to the use of cookies by DNAnexus and necessary third parties in accordance to the Privacy Policy and Terms of Services. DNAnexus may use third-party services for this purpose. I can revoke my consent anytime by visiting the Cookies Settings page.